None listed
Conditions
Interventions
Intervention1: Nanocurcumin 6C and Nanocurcumin 30C: Homoeopathic medicine-Nanocurcumin 6C or 30C, 4 pills of size 30 in each dose, shall be given fortnightly from March to May (3 months), weekly from
Sponsors
Central Council for Research in Homoeopathy, Ministry of AYUSH, Government of India
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy individuals of either sex, aged 1 year or above living in the same community in the endemic area of malaria. 2. Written Informed consent by the family head. 3. No symptoms of malaria at the time of enrolment in the study.
Exclusion criteria
Exclusion criteria: 1. Symptoms of malaria or fever in the last 7 days. 2. Pregnant women and lactating mothers. 3. Child below the age of 1 year. 4. Individuals taking other preventive medicines for malaria. 5. Patients with malignancy, immunocompromised state, life-threatening diseases, end-stage diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the incidence of Malaria Fever between the groupsTimepoint: Weekly | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in incidence of asymptomatic parasitemia between the groupsTimepoint: At the time of Analysis;Changes in mean parasite density between the groupsTimepoint: At the time of Analysis;Changes in the incidence of Acute Febrile Illness between the groupsTimepoint: Weekly;Changes in the incidence of other acute illnesses (Acute Diarrhoeal Disease, Acute Respiratory Infection/ Influenza Like Illness) between the groupsTimepoint: Weekly;Changes in the incidence of severe malaria between the groupsTimepoint: Weekly;Requirement for hospitalization between the groupsTimepoint: At the time of Analysis | — |
Countries
India
Contacts
Public ContactDr Ratan Chandra Shil
Central Council for Research in Homoeopathy
Outcome results
None listed